Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PANK1 antisense RNA 1 (PANK1-AS1) is a long non-coding RNA (lncRNA) that is transcribed from the antisense strand at the PANK1 gene locus. Antisense RNAs such as PANK1-AS1 typically regulate the expression of their corresponding sense genes—in this case, pantothenate kinase 1 (PANK1)—either by interfering with transcription, modifying chromatin structure, or affecting the stability of sense mRNA transcripts[3][6]. While the general function of antisense RNAs is to modulate gene expression at transcriptional and post-transcriptional levels, specific biological roles for PANK1-AS1 have not been well characterized in the current literature. There is thus insufficient evidence that PANK1-AS1 itself functions as a direct therapeutic target such as a receptor, enzyme, or transporter. Instead, it likely exerts regulatory effects, particularly in processes involving gene expression control and possibly epigenetic regulation[3][6]. Antisense RNAs are of interest in disease settings, especially cancer, due to their roles in gene regulation, but direct disease associations and pharmacological targeting of PANK1-AS1 have not yet been reported. Note: - This entry is distinct from PANK1 (pantothenate kinase 1), the protein-coding gene/enzyme, which is a therapeutic target involved in CoA biosynthesis[4][8][10]. - No drugs or biomarkers are currently associated with PANK1-AS1 specifically. - There are no established safety concerns because it is not a direct therapeutic target; however, manipulation of lncRNAs can have broad effects given their key regulatory functions[3][6].
Transcriptional interference with sense gene. Modulation of chromatin state. mRNA stability alteration. Potential involvement in imprinting. Post-transcriptional regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PANK1 antisense RNA 1 (PANK1-AS1).